|
Company
Roster
|
Total
Insiders : |
44 |
|
|
Total
Direct Shares :
|
16,949,908 |
|
Total
Indirect Shares :
|
27,515,787 |
|
%
Held by Insiders:
|
85.87% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Kovner Bruce |
Director, 10% Owner |
2015-12-08 |
3,092,677 |
2015-12-08 |
18,019,580 |
Chen Lin Huey |
10% Owner |
|
0 |
2009-11-20 |
2,570,947 |
Baker Brothers Life Sciences Lp |
Director |
2023-11-14 |
0 |
2023-12-14 |
1,793,403 |
Gollust Keith R |
Director |
2015-12-14 |
401,764 |
2015-12-14 |
1,714,169 |
Chen Lan Bo |
Director |
2011-12-06 |
666,262 |
2011-12-06 |
1,436,283 |
Taub Rebecca |
|
2024-04-08 |
458,999 |
2024-04-08 |
655,540 |
Friedman Paul A |
|
2024-04-08 |
185,735 |
2024-04-08 |
655,540 |
Bahcall Safi R |
President and CEO, Director |
2013-11-13 |
2,053,135 |
2013-11-13 |
480,000 |
Bay City Capital Fund Llc |
Director, 10% Owner |
2018-06-11 |
0 |
2018-06-11 |
113,472 |
Craves Fred B |
|
2024-05-14 |
413,362 |
2024-05-14 |
76,323 |
Lynch Brian Joseph |
|
2024-01-23 |
17,691 |
2024-01-23 |
530 |
Williams Martin D |
Sr. VP, Business Dev., CBO |
2007-11-16 |
0 |
2007-02-09 |
0 |
Bailey Michael P |
Sr. VP, Chief Comm. Officer |
2010-08-05 |
29,627 |
2008-08-04 |
0 |
Ramachandra Sumant |
President, R&D |
2013-03-11 |
75,000 |
2013-03-11 |
0 |
Kufe Donald W |
Director |
2013-07-01 |
25,748 |
2012-07-01 |
0 |
Singh Amar |
Sr. VP, Chief Business Officer |
2013-12-02 |
15,161 |
2010-11-29 |
0 |
Bernitz Steven B |
SVP, Corporate Development |
2013-12-18 |
25,000 |
2013-12-18 |
0 |
Whitaker Anne Clem |
President and CEO, Director |
2014-09-02 |
500,000 |
2014-09-02 |
0 |
Morenstein Scott D |
Director |
2016-01-01 |
17,857 |
2016-01-01 |
0 |
Schor Chen |
Former President and CEO, Director |
2016-07-22 |
37,178 |
2014-12-08 |
0 |
Schneebaum Marc R |
Chief Financial Officer |
2018-06-11 |
41,668 |
2014-12-08 |
0 |
Milligan David V |
Director |
2018-11-21 |
0 |
2018-09-18 |
0 |
Bay City Capital Fund Iv Co Invesment Fund Lp |
10% Owner |
2021-12-03 |
1,261 |
2021-12-03 |
0 |
Sukhija Remy |
Chief Commercial Officer |
2023-01-16 |
15,001 |
2022-12-23 |
0 |
Sibold William John |
|
2024-01-23 |
62,250 |
2023-09-11 |
0 |
Howarth Alex G. |
|
2024-01-23 |
18,737 |
2023-01-16 |
0 |
Huntsman Carole |
|
2024-01-23 |
11,473 |
2023-11-20 |
0 |
Levy Richard S |
|
2024-04-01 |
10,298 |
2017-08-21 |
0 |
Daly James M |
Director |
2024-04-02 |
1,198 |
2024-04-01 |
0 |
Bate Kenneth |
Director |
2024-04-02 |
1,198 |
2024-04-01 |
0 |
Waltermire Robert E. |
|
2024-05-21 |
5,500 |
2023-01-16 |
0 |
Barsoum James G |
Officer |
2007-02-05 |
40,000 |
|
0 |
Caxton Corp |
10% Owner |
2007-02-09 |
7,761,716 |
|
0 |
Jacobson Eric W |
Sr. VP, Research and CMO |
2007-02-09 |
25,300 |
|
0 |
Folkman Judah |
Director |
2007-06-30 |
7,676 |
|
0 |
Chadwick Jeremy G |
Sr. VP, Pgm Mgmt and Clin Ops |
2009-01-05 |
15,853 |
|
0 |
Koya Keizo |
Sr. VP, Drug Development |
2012-03-01 |
12,999 |
|
0 |
Ehrlich Keith S |
VP, Fin. and Admin., CFO |
2012-03-01 |
17,573 |
|
0 |
Vukovic Vojo |
SVP, Chief Medical Officer |
2013-06-05 |
35,249 |
|
0 |
Mcmahon Arthur |
Officer |
2014-01-03 |
12,829 |
|
0 |
Wilson Robert N |
Director |
2015-07-01 |
760,936 |
|
0 |
Reardon William S |
Director |
2015-07-01 |
49,392 |
|
0 |
Rieder Wendy E |
Former SVP, Gen. Counsel |
2016-07-22 |
17,730 |
|
0 |
Dier Mardi |
|
2024-03-11 |
8,875 |
|
0 |
|